Bio-Matrix Scientific Group, Inc. (PINKSHEETS: BMSN), Tranzbyte Corporation. (PINKSHEETS: ERBB), MediSwipe, Inc. (OTCQB: MWIP), Amarantus BioScience, Inc. (OTCQB: AMBS).

Bio-Matrix Scientific Group, Inc. (BMSN) saw shares advancing $0.002 or 57.14% to close the day at $0.158 on volume of 12,320,821 shares traded during yesterday's trading session. Tuesday morning the company announced the filing of an Investigational New Drug (IND) application with the FDA to initiate clinical trials assessing the company's HemaXellerate I™ stem cell drug in patients with drug-refractory aplastic anemia. Will this positive news spark a further rally in the days to come? Find out in our exclusive report at: http://squawkboxstocks.com/report/BMSN

Tranzbyte Corporation. (ERBB) was another big gainer seeing shares rise 57.50% to close the day at $0.0063 on 186,436,985 shares traded. The stock has now gained 110% since January 28th when the company announced it has exclusively partnered with Native-American owned U-Mate International Inc. to develop their specialized product line formulated specifically for the cannabis industry. Will this positive news lead to further gains ahead or will the stock finally give up some of it's recent gains? Find out more in our exclusive report at: http://squawkboxstocks.com/report/ERBB

MediSwipe, Inc. (MWIP) was another stock seeing increased activity during yesterday's trading session. The company saw shares close nearly flat on the day at $0.0414 after seeing an intraday high of $0.046 on volume of 20,335,557 shares exchanging hands. The company, a patient security solutions and financial products company for the medicinal marijuana and health care industry, announced that it has received new order requests from several medical marijuana dispensaries for its digital patient identification cards and MediPay kiosks. MediSwipe will provide at least 5,000 new digital record cards for patients in conjunction with three MediPay kiosks to Michigan based dispensaries. Find out if this positive announcement will lead to a higher stock price or if its time for the stock to see a retrace in our exclusive report at: http://squawkboxstocks.com/report/MWIP

Amarantus BioScience, Inc. (AMBS) saw its shares decline 6.90% to close yesterday at $0.081 on volume of 5,223,417 shares traded. On Monday the biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis centered around its patented therapeutic protein MANF, reported that upon further analysis of the data reported on January 9th, 2013, the striatal reinnervation (densitometry) data produced in the 6 hydroxydopamine (6-OHDA) neurorestoration rat model of Parkinson's disease for MANF at 36ug achieved a statistically significant improvement over the data produced for GDNF, with a P value of 0.047. Investors didn't seem to like the news, but is a bounce coming or will shares see a further decline in value? Find out in our exclusive report at: http://squawkboxstocks.com/report/AMBS

About http://SquawkBoxStocks.com

Squawk Box Stocks offers its daily stock alerts and market content newsletter to investors looking for timely information available! Our experienced team provides you only the best stock alerts & research reports delivered to your email inbox for FREE. Our track record of providing winning alerts has won us the trust of thousands of investors worldwide. With our dedicated research team & investor database continuing to grow we have become a leading destination for the most profitable opportunities that are available in today's stock market. To receive our FREE, comprehensive newsletter, visit http://SquawkBoxStocks.com.

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Winning Media LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information: Winning Media LLC 1-800-411-7716 Email Contact

Agritek (CE) (USOTC:AGTK)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 Agritek (CE) 차트를 더 보려면 여기를 클릭.
Agritek (CE) (USOTC:AGTK)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 Agritek (CE) 차트를 더 보려면 여기를 클릭.